Sell to close the December 60 CACI International call option (CAI + LL) at the market for a profit of roughly 70 percent in just two days. We added the CACI International (CAI) call option this past Monday on expectations that the stock would rally following the release of the company's third-quarter earnings report today. Read More
Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.
Analyst Articles
Buy to open the December 60 CACI International (CAI) call option (CAI + LL). Set a limit to pay no more than $3.00 per contract. Read More
October 19, 2005 Sell to close the General Electric December 32.50 call option (GE + LZ) for a loss of about 30 percent. General Electric (GE) reported solid third quarter earnings last Friday. The company's revenue expanded by a healthy 9 percent to $41.9 billion in the period. Read More
October 11, 2005 Buy to open the EnCana (ECA) January 55 call option (ECA +AK) at the market. Oil prices were under pressure on fears that demand is lessening in the wake of the high prices that have prevailed in recent months. Read More
Buy to open the Philadelphia Gold/Silver Index (XAU) December 110 call option (XAV +LB). Pay no more than $6.40 for the call. Virtually every measure of inflation is accelerating right now. And all evidence points to it getting worse as we move forward. Read More
Buy to close the ExxonMobil January 60 put option (XOM + ML) you previously wrote (sold) for about 50 percent loss. Energy stocks across the board have come under intense selling pressure due to fears that demand is tapering off. Read More
October 6, 2005 Buy to open the EnCana January 50 Call option (ECA +AK) at the market. Oil prices fell to their lowest levels in two months today on fears that demand is lessening in the wake of the high prices that have prevailed in recent months. Read More
Sell to Close the Amylin Pharmaceuticals April 30 call option (AQM + DF) and Buy to Open the Amylin April 40 call option (AQM + DH) in its place. Place both trades at the market. Amylin Pharmaceuticals (AMLN) Read More
Sell to close the Genentech January 85 (DWN + AQ) call option at the market for a gain of 25 percent in just four days. Genentech (DNA) is a great growth stock, but given its lofty valuations it's prone to wide price swings. Read More
Sell to close your the November 124 S&P 500 Depositary Receipts (SPY) call option (SPY + KT) at the market for a loss of about 50 percent. Read More